Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ESTA logo ESTA
Upturn stock ratingUpturn stock rating
ESTA logo

Establishment Labs Holdings Inc (ESTA)

Upturn stock ratingUpturn stock rating
$41
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/28/2025: ESTA (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

8 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $55.44

1 Year Target Price $55.44

Analysts Price Target For last 52 week
$55.44 Target price
52w Low $26.55
Current$41
52w High $50.85

Analysis of Past Performance

Type Stock
Historic Profit -38.65%
Avg. Invested days 32
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/28/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.19B USD
Price to earnings Ratio -
1Y Target Price 55.44
Price to earnings Ratio -
1Y Target Price 55.44
Volume (30-day avg) 8
Beta 0.83
52 Weeks Range 26.55 - 50.85
Updated Date 08/28/2025
52 Weeks Range 26.55 - 50.85
Updated Date 08/28/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.08

Analyzing Revenue: Products, Geography and Growth

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-08-07
When -
Estimate -0.53
Actual -0.57

Profitability

Profit Margin -49.89%
Operating Margin (TTM) -27.5%

Management Effectiveness

Return on Assets (TTM) -12.78%
Return on Equity (TTM) -261.18%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 1405994035
Price to Sales(TTM) 6.69
Enterprise Value 1405994035
Price to Sales(TTM) 6.69
Enterprise Value to Revenue 7.92
Enterprise Value to EBITDA -26.29
Shares Outstanding 28970700
Shares Floating 16952516
Shares Outstanding 28970700
Shares Floating 16952516
Percent Insiders 10.74
Percent Institutions 104.33

ai summary icon Upturn AI SWOT

Establishment Labs Holdings Inc

stock logo

Company Overview

overview logo History and Background

Establishment Labs Holdings Inc. was founded in 2004. It is a global medical technology company focused on breast aesthetics and reconstruction technologies. The company has focused on innovation and expanding its global reach.

business area logo Core Business Areas

  • Breast Aesthetics: Develops, manufactures, and markets a portfolio of silicone gel-filled breast implants, primarily Motiva Implants, for aesthetic enhancement.
  • Breast Reconstruction: Offers products for breast reconstruction procedures following mastectomy due to breast cancer.
  • Early Detection: Develops and offers products for breast health, including early detection technologies.

leadership logo Leadership and Structure

Juan Josu00e9 Chacu00f3n-Quiru00f3s is the CEO. The company has a board of directors and a management team overseeing different functions like R&D, sales, marketing, and operations. The structure is a typical multinational corporation with regional headquarters.

Top Products and Market Share

overview logo Key Offerings

  • Motiva Implants: Motiva Implants are its flagship product, a line of silicone gel-filled breast implants known for their advanced surface technology and safety features. Market share data fluctuates but estimates range from 10-15% globally. The competitors are Allergan (ABBV), Mentor (JNJ), Sientra (SIEN).
  • Divina Breast Reconstruction System: The Divina breast reconstruction system aids in breast reconstruction procedures by providing surgeons with a comprehensive solution. Market share is growing but still relatively small. Competitors include Allergan (ABBV), Mentor (JNJ).

Market Dynamics

industry overview logo Industry Overview

The global breast implant market is driven by increasing demand for aesthetic procedures and breast reconstruction. The market is moderately consolidated, with a few major players dominating. Growth is fueled by technological advancements and rising disposable incomes.

Positioning

Establishment Labs positions itself as a premium provider of innovative and safe breast implant technologies, focusing on patient safety and aesthetic outcomes. Their competitive advantage lies in their advanced Motiva implant technology and focus on minimizing complications.

Total Addressable Market (TAM)

The total market is estimated around $2 billion. Establishment Labs is well positioned in this market focusing on growth and innovation.

Upturn SWOT Analysis

Strengths

  • Innovative product portfolio (Motiva Implants)
  • Strong brand reputation
  • Focus on safety and aesthetics
  • Global presence with strong growth in key markets
  • Proprietary technology

Weaknesses

  • Relatively smaller market share compared to larger competitors
  • Higher price point may limit market reach
  • Reliance on regulatory approvals for new products
  • Geographic concentration of manufacturing
  • Requires substantial investment in R&D and marketing.

Opportunities

  • Expanding into new geographic markets
  • Developing new products and technologies
  • Increasing awareness of breast reconstruction options
  • Strategic partnerships and acquisitions
  • Capitalizing on the growing demand for aesthetic procedures

Threats

  • Competition from established players with larger market share
  • Product liability claims and recalls
  • Changing regulatory landscape
  • Economic downturn affecting consumer spending
  • Adverse publicity regarding breast implant safety

Competitors and Market Share

competitor logo Key Competitors

  • ABBV
  • JNJ
  • SIEN

Competitive Landscape

Establishment Labs differentiates itself through innovation and product safety. However, its smaller size and higher price point present challenges against larger competitors.

Growth Trajectory and Initiatives

Historical Growth: Establishment Labs has experienced strong revenue growth in recent years.

Future Projections: Analysts project continued revenue growth driven by geographic expansion and new product launches.

Recent Initiatives: Recent initiatives include expanding production capacity, pursuing regulatory approvals in key markets, and investing in clinical trials.

Summary

Establishment Labs is an innovative company in the breast aesthetics market with a focus on safety and aesthetics. The company faces strong competition from larger players and needs to successfully expand into new markets. Continuous regulatory approvals are critical for its success and financial stability. Overall, the company is considered to be very strong with solid results year on year.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings (SEC)
  • Analyst Reports
  • Industry Publications

Disclaimers:

The data provided is based on available information and estimates. Market share figures are approximate and subject to change. Investment decisions should be based on thorough research and consultation with a financial advisor.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Establishment Labs Holdings Inc

Exchange NASDAQ
Headquaters -
IPO Launch date 2018-07-19
CEO & Director Mr. Fillipo Peter Caldini
Sector Healthcare
Industry Medical Devices
Full time employees 1056
Full time employees 1056

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.